Bordewijk, E. M.Jannink, T. I.Weiss, N. S.de Vries, T.Nahuis, M.Hoek, A.Goddijn, M.Mol, B. W.van Wely, M.M-ovin study group2023-08-092023-08-092023-03Bordewijk, E M, Jannink, T I, Weiss, N S, de Vries, T, Nahuis, M, Hoek, A, Goddijn, M, Mol, B W, van Wely, M & M-ovin study group 2023, 'Long-term outcomes of switching to gonadotrophins versus continuing with clomiphene citrate, with or without intrauterine insemination, in women with normogonadotropic anovulation and clomiphene failure : follow-up study of a factorial randomized clinical trial', Human reproduction (Oxford, England), vol. 38, no. 3, pp. 421-429. https://doi.org/10.1093/humrep/deac2680268-1161unpaywall: 10.1093/humrep/deac268https://hdl.handle.net/2164/21441We thank all couples who participated in the trial as well as the hospitals and their staff. Funding The original study received funding from the Dutch Organization for Health Research and Development (ZonMw number: 80-82310-97-12067).9497098engclomiphene citratecumulative live birthgonadotrophinsovulation inductionPCOSInseminationFollow-Up StudiesClomiphene/therapeutic useHumansLive BirthOvulation Induction/methodsPregnancyGonadotropins/therapeutic useAnovulation/complicationsFemaleInfant, NewbornPregnancy RateRG Gynecology and obstetricsObstetrics and GynaecologyReproductive MedicineRGLong-term outcomes of switching to gonadotrophins versus continuing with clomiphene citrate, with or without intrauterine insemination, in women with normogonadotropic anovulation and clomiphene failure : follow-up study of a factorial randomized clinical trialJournal article10.1093/humrep/deac268http://www.scopus.com/inward/record.url?scp=85149173349&partnerID=8YFLogxK383